Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - jorrit hegge
A method for highly selective nucleic acid enrichment for sensitive detection of mutations in cancer and genectic conditions.
This technology increases the fraction of clinically relevant, rare mutant alleles (DNA and/or RNA) to enable high sensitivity detection with common downstream methods such as capped (XNA or PNA) PCR, ddPCR, and sequencing. Problem: Liquid biopsy is a simple, minimally invasive, rapidly developing diagnostic method to analyze cell-free nucleic...
John van der Oost
Hardware & Circuits & Sensors
Research Tools & Reagents
Veterinary & Animal Health
© 2020. All Rights Reserved. Powered by